Vital role of quality assurance as a backbone in pharmaceutical industry
DOI:
https://doi.org/10.7439/ijap.v4i6.2688Keywords:
Depression, etiological factors, pathogenesis, TreatmentAbstract
The overview on the vital role of a Quality Assurance department in a pharmaceutical industry and how it is related to other departments as an important factor is well discussed in each subsection. It also explains on how Quality Assurance can increase the revenue of the industry and it also explains on the work flow from the raw material till the finished product and the role of Quality Assurance in each flow. It gives a clear picture on how the Quality Assurance is manage and gives ideas on how to enhance the flow. The role of Quality Assurance in regulatory affairs and also business development is explained.Downloads
References
Lawrence, X. Y. (2008). Pharmaceutical quality by design: product and process development, understanding, and control. Pharmaceutical research, 25(4), 781-791.
Banker, G. S., Siepmann, J., & Rhodes, C. (Eds.). (2002). Modern pharmaceutics. CRC Press.
Guideline, I. H. T. (2000). Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Q7A, Current Step, 4.
Ezzelle, J., Rodriguez-Chavez, I. R., Darden, J. M., Stirewalt, M., Kunwar, N., Hitchcock, R., ... & D'souza, M. P. (2008). Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. Journal of pharmaceutical and biomedical analysis, 46(1), 18-29.
Cardinal, L. B. (2001). Technological innovation in the pharmaceutical industry: The use of organizational control in managing research and development.Organization science, 12(1), 19-36.
Huang, J., Kaul, G., Cai, C., Chatlapalli, R., Hernandez-Abad, P., Ghosh, K., & Nagi, A. (2009). Quality by design case study: an integrated multivariate approach to drug product and process development. International journal of pharmaceutics, 382(1), 23-32.
Rodionova, O. Y., Sokovikov, Y. V., & Pomerantsev, A. L. (2009). Quality control of packed raw materials in pharmaceutical industry. analytica chimica acta, 642(1), 222-227.
Huber, L. (1998). Validation of analytical methods. Validation and Qualification in the Analytical Laboratories, Interpharm Press, Buffalo Grove, IL, 107.
Agalloco, J. P., & Carleton, F. J. (Eds.). (2007). Validation of pharmaceutical processes. CRC Press.
Ermer, J., & Miller, J. H. (2014). Method validation in pharmaceutical analysis. Wiley.
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (Eds.). (2009). Handbook of pharmaceutical excipients (Vol. 6, p. 888). London: Pharmaceutical press.
Bakshi, M., & Singh, S. (2002). Development of validated stability-indicating assay methods
Khanna, I. (2012). Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug discovery today, 17(19), 1088-1102.
Cockburn, I. M. (2004). The changing structure of the pharmaceutical industry.Health Affairs, 23(1), 10-22.
Carpenter, D. P. (2004). The political economy of FDA drug review: processing, politics, and lessons for policy. Health Affairs, 23(1), 52-63.
Kayser, O., & Warzecha, H. (2012). Pharmaceutical biotechnology: drug discovery and clinical applications. John Wiley & Sons.
Lund, W. (1994). The pharmaceutical codex: principles and practice of pharmaceutics (No. Ed. 12). Royal Pharmaceutical Society of Great Britain.
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: systematic review.Bmj, 326(7400), 1167-1170.
Smith, M. C. (2014). Principles of pharmaceutical marketing. Routledge.
Henderson, R., Orsenigo, L., & Pisano, G. P. (1999). The pharmaceutical industry and the revolution in molecular biology: interactions among scientific, institutional, and organizational change. Sources of industrial leadership: studies of seven industries, 267-311
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).